Skip to content
June 9, 2025
  • Facebook
  • Twitter
  • Instagram
  • Youtube
  • tiktok
MILLENNIUM NEWS 24/7

MILLENNIUM NEWS 24/7

Bridging The Community’s World Wide

  • Home
  • IP TV LIVE
  • PODCAST
  • U.S.News
  • LOCAL ELECTION
  • State News
    • Alabama
    • Alaska
    • Arizona
    • Arkansas
    • California
    • Colorado
    • Connecticut
    • Delaware
    • Florida
    • Georgia
    • Hawaii
    • Idaho
    • Illinois
    • Indiana
    • Iowa
    • Kansas
    • Kentucky
    • Louisiana
    • Maryland
    • Massachusetts
    • Michigan
    • Maine
    • Minnesota
    • Mississippi
    • Missouri
    • Montana
    • Nebraska
    • Nevada
    • New Hampshire
    • New Jersey
    • New Mexico
    • New York
    • North Carolina
    • North Dakota
    • Oregon
    • Pennsylvania
    • Rhode Island
    • South Carolina
    • South Dakota
    • Tennessee
    • Texas
    • Virginia
    • Washington
    • West Virginia
    • U.S. Virgin Islands
  • Politics
  • World News
  • Sports
  • Entertainment
  • Weather
  • Business
  • Advisement
  • Health News
  • About Us
  • Contact us
Live TV

CVS Health pulls some cough-and-cold treatments with ingredient deemed ineffective by doctors

CVS Health is pulling from its shelves some cough-and-cold treatments that contain an ingredient that has been deemed ineffective by doctors and researchers.

The drug store chain said it will remove a small number of oral decongestants that contain phenylephrine as the only active ingredient. CVS also said it will still sell “many other oral cough and cold products to meet consumer needs.”

A company spokeswoman declined to elaborate on how many products will be removed when contacted by The Associated Press Friday morning.

CVS Health runs more than 9,000 stores in the United States. Representatives of its national rival, Walgreens, has not pulled any products.

A Walgreens spokeswoman said the company is monitoring the situation and partnering with its clinical integrity office and suppliers “on appropriate next steps.”

U.S. Food and Drug Administration advisers voted unanimously last month against the effectiveness of phenylephrine, which is found in popular versions of Sudafed, Dayquil and other medications stocked on store shelves.

The FDA had asked its outside advisers to examine the long-questioned drug ingredient. Studies conducted in the past few years by the drugmakers Merck and Johnson & Johnson have shown no difference between phenylephrine medications and placebos for relieving congestion.

The FDA, which has not acted on the recommendation of its advisers, said the drug appears more effective when applied directly to the nose, in sprays or drops. Those products are not under review.

Phenylephrine had become the main drug in over-the-counter decongestants when medicines with an older ingredient — pseudoephedrine — were moved behind pharmacy counters. A 2006 law had forced the move because pseudoephedrine can be illegally processed into methamphetamine.

Those original versions of Sudafed and other medicines remain available without a prescription.

The CVS Health announcement comes shortly before another cold-and-flu season starts in the United States as winter sets in. Last year, an unusually fast start to the season led to shortages of Children’s Tylenol and other medications customers can purchase over-the-counter, or without a prescription.

 

 

About Author

dreamboy

See author's posts

Continue Reading

Previous: Stock market today: Asian shares slip further as higher US 10-year Treasury yield pressures Wall St
Next: There isn’t much Cher hasn’t done in her career. A Christmas album is new territory, though

Related Stories

Amazon launches its first internet satellites to compete against SpaceX’s Starlinks

Amazon launches its first internet satellites to compete against SpaceX’s Starlinks

Trump administration says it will exclude some electronics from reciprocal tariffs

Trump administration says it will exclude some electronics from reciprocal tariffs

Apple has few incentives to start making iPhones in US, despite Trump’s trade war with China

Apple has few incentives to start making iPhones in US, despite Trump’s trade war with China

Entertainment

Tom Cruise brings ‘Final Reckoning’ to Cannes, but won’t bid ‘Mission: Impossible’ adieu yet 1

Tom Cruise brings ‘Final Reckoning’ to Cannes, but won’t bid ‘Mission: Impossible’ adieu yet

‘SNL’ to close out its 50th season with Scarlett Johansson and Bad Bunny 2

‘SNL’ to close out its 50th season with Scarlett Johansson and Bad Bunny

Jen Psaki stepping up for MSNBC as Rachel Maddow returns to once-a-week schedule 3

Jen Psaki stepping up for MSNBC as Rachel Maddow returns to once-a-week schedule

Book publishers see surging interest in the US Constitution and print new editions 4

Book publishers see surging interest in the US Constitution and print new editions

What to know about Harvey Weinstein’s #MeToo retrial with jury selection set to get underway 5

What to know about Harvey Weinstein’s #MeToo retrial with jury selection set to get underway

Ahead of spaceflight, Katy Perry is reading Carl Sagan and channeling her ‘feminine divine’ 6

Ahead of spaceflight, Katy Perry is reading Carl Sagan and channeling her ‘feminine divine’

British police charge comedian Russell Brand with rape and sexual assault 7

British police charge comedian Russell Brand with rape and sexual assault

Top News

Trump and Musk break up, and Washington holds its breath

Trump and Musk break up, and Washington holds its breath

Musk calls Trump’s big tax break bill a ‘disgusting abomination,’ testing his influence over the GOP

Musk calls Trump’s big tax break bill a ‘disgusting abomination,’ testing his influence over the GOP

Ukraine’s backers meet to drum up arms and ammo. The Pentagon chief is absent for the first time

Ukraine’s backers meet to drum up arms and ammo. The Pentagon chief is absent for the first time

Ukraine’s drone attack on Russian warplanes was a serious blow to the Kremlin’s strategic arsenal

Ukraine’s drone attack on Russian warplanes was a serious blow to the Kremlin’s strategic arsenal

  • Home
  • About Us
  • Facebook
  • Twitter
  • Instagram
  • Youtube
  • tiktok
Editor: Nur M Tofader, Head Office: 544 Taylor Avenue Bronx New York USA 10473, Tell: 7186396600, 7186396800, 7188441300, Email: Info@millenniuamnews24.com, Copyright © Millennium News 24/7 | DarkNews by AF themes.